Gilead Sciences (GILD) Retained Earnings (2009 - 2026)

Gilead Sciences has reported Retained Earnings for 18 years, with the latest figure at $78.0 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 99.29% year-over-year to $78.0 million; the trailing twelve-month figure through Mar 2026 stood at $78.0 million (down 99.29% YoY), and the FY2025 full-year result was $39.0 million, down 70.45% from the prior year.
• Retained Earnings for Q1 2026 stood at $78.0 million, up from $39.0 million in the prior quarter.
• The five-year high for Retained Earnings was $16.0 billion in Q3 2023, with the low at -$18.0 million in Q2 2025.
• Historically, Retained Earnings has averaged $6.6 billion across 5 years, with a median of $132.0 million in 2024.
• Annual changes were most pronounced in 2024 — Retained Earnings surged 111550.0% — and 2025, when it slumped 100.16%.
• Gilead Sciences' Retained Earnings stood at $15.7 billion in 2022, then plunged by 99.82% to $28.0 million in 2023, then surged by 371.43% to $132.0 million in 2024, then sank by 70.45% to $39.0 million in 2025, then surged by 100.0% to $78.0 million in 2026.
• The last three Retained Earnings figures came in at $78.0 million (Q1 2026), $39.0 million (Q4 2025), and $12.8 billion (Q3 2025), per Business Quant data.